2024: Tromboz, Gemostaz i Reologiya, Nr. 3 | Tromboz, Gemostaz I Reologiya

Sergey M. Markin, Pavel F. Kravtsov, Anastasia S. Artemova, Evgeny A. Ilyukhin

19-27

Conservative and surgical treatment of deep vein thrombosis: choice of the professional surgical community: 616‐005.6:617‐089

Svetlana V. Topolyanskaya, Leonid I. Bubman, Yulia Yu. Vasilyeva, Maria V. Golimbekova, Ksenia D. Melnikova, Karine A. Lytkina, Georgiy G. Melkonyan

28-38

Venous thromboembolic complications in wounded with combat-related extremity injuries: 616-005.6

Dana E. Pavlova, Nikolai P. Leonov, Pavel G. Madonov, Pavel E. Trakhtman, Svetlana V. Iamatina, Elena A. Spiridonova, Nikolai S. Grachev, Andrey Yu. Bulanov

39-50

Hemostasis in children with surgical oral and maxillofacial pathology: 616.151.5:617.51/53

Marine M. Tanashyan, Marina Yu. Maksimova, Eugene V. Roitman

51-57

Hematological parameters in patients with internal carotid artery atherosclerotic stenosis during tooth extraction: 616‐08‐031.84:616.314‐74:615.036

Alina R. Gasanbekova, Irina P. Yastrebtseva, Olga A. Pakhrova

58-66

Hemorheological parameters during rehabilitation with transcranial micropolarization in patients in the early post-stroke recovery period: 616.8‐085.84

Ruslan I. Damdinov , Konstantin G. Shapovalov, Natalia I. Troitskaya, Aleksey V. Solpov

67-74

Platelet aggregation and adhesion in diabetic foot: 616.379‐036.11‐07‐092:617.586

Alina A. Nabieva, Dmitry A. Kudlay, Albina Kh. Tregubova, Bulat A. Bakirov, Dmitry V. Morozovsky, Valentina V. Efimova, Alexey A. Ladutko

75-86

Clinical and laboratory features of COVID‐19‐patients in severe and extremely severe condition: 616‐06

Sabina M. Gasanova, Галина Николаевна Кузьменко, Angelina K. Krasilnikova, Irina G. Popova, Sergey B. Nazarov

87-96

Hemostasis in women with abnormal uterine bleedings and endometrial hyperplasia: 612.115:618.145‐007.61‐005.1

Nadezhda I. Zozulya, Tatiana A. Andreeva, Viсtor Yu. Petrov, Valeriia N. Konstantinova, Olga A. Krasheninnikova, Inna N. Lavrentyeva, Pavel V. Svirin, Oleg G. Melikhov

97–106

Changes in clinical and laboratory parameters in adolescents and young adults with hemophilia A after switching from standard half-life factor VIII to efmoroctocog alfa: 616.151.5

Olga S. Beznoshchenko, Tatiana A. Fedorova, Elena V. Strelnikova, Elena A. Gorodnova, Аlexey V. Pyregov, Borislav V. Silaev

107–117

Clinical significance of thromboelastometry parameters: 616‐005.1‐08

2024

Review

Original papers